Latest Financial Results
Q2 2024
Quarter Ended Jun 30, 2024
Email Alerts
Stay informed and receive company updates straight to your inbox.
Stock Information
Company Overview
Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.
Investor Contact Information
Company
Ocuphire Pharma, Inc.
37000 Grand River Ave., Suite 120
Farmington Hills, MI 48335
T: 248-957-9024
[email protected]
Investor Relations
LifeSci Advisors
250 West 55th Street, Suite 3401
New York, NY 10019
T: 646-889-1200
[email protected]
Transfer Agent
Equiniti Trust Company, LLC (“EQ”)
48 Wall Street, Floor 23
New York, NY 10005
T: 800-468-9716
www.equiniti.com